TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer-Reference-Cited by-同舟云学术

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

Published:2014-07-31 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Banerjee Rajat,Russo Nickole,Liu Min,Basrur Venkatesha,Bellile Emily,Palanisamy Nallasivam,Scanlon Christina S.,van Tubergen Elizabeth,Inglehart Ronald C.,Metwally Tarek,Mani Ram-Shankar,Yocum Anastasia,Nyati Mukesh K.,Castilho Rogerio M.,Varambally Sooryanarayana,Chinnaiyan Arul M.,D’Silva Nisha J.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms5527.pdf

Reference63 articles.

1. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9–22 (2011).

2. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010).

3. Chapman, J. R., Taylor, M. R. & Boulton, S. J. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47, 497–510 (2012).

4. Kass, E. M. & Jasin, M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett. 584, 3703–3708 (2010).

5. Jeggo, P. A. & Lobrich, M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 26, 7717–7719 (2007).

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIP13 − a potential drug target in cancer pharmacotherapy;Bioorganic Chemistry;2024-10

2. A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma;Scientific Reports;2024-09-11

3. Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma;Bioorganic & Medicinal Chemistry;2024-09

4. TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21;Cell Death & Disease;2024-08-26

5. Removal of the catalytic subunit of DNA-protein kinase in the proximal tubules promotes DNA and tubular damage during kidney injury;2024-08-23